The FDA has accepted a biologics license application for Blenrep plus bortezomib or pomalidomide for patients with relapsed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback